PE Ratio Chart

View PE Ratio for BVNKF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PE Ratio Chart
Start Trial

Historical PE Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
August 27, 2026 10.43
August 26, 2026 10.43
August 25, 2026 10.43
August 24, 2026 10.43
August 21, 2026 10.43
August 20, 2026 8.864
August 19, 2026 8.864
August 18, 2026 8.864
August 17, 2026 8.864
August 14, 2026 8.864
August 13, 2026 8.864
August 12, 2026 8.864
August 11, 2026 8.864
August 10, 2026 8.864
August 07, 2026 8.864
August 06, 2026 8.864
August 05, 2026 8.864
August 04, 2026 8.864
August 03, 2026 8.864
July 31, 2026 8.864
July 30, 2026 8.864
July 29, 2026 8.864
July 28, 2026 8.864
July 27, 2026 8.864
July 24, 2026 8.864
Date Value
July 23, 2026 8.864
July 22, 2026 8.864
July 21, 2026 8.864
July 20, 2026 8.864
July 17, 2026 8.864
July 16, 2026 8.864
July 15, 2026 8.864
July 14, 2026 8.864
July 13, 2026 8.864
July 10, 2026 8.864
July 09, 2026 8.864
July 08, 2026 8.864
July 07, 2026 8.864
July 06, 2026 8.864
July 02, 2026 8.864
July 01, 2026 8.864
June 30, 2026 8.864
June 29, 2026 11.87
June 26, 2026 11.92
June 25, 2026 11.92
June 24, 2026 11.92
June 23, 2026 11.92
June 22, 2026 11.92
June 18, 2026 11.92
June 17, 2026 11.92

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

View PE Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PE Ratio Benchmarks

View PE Ratio Benchmarks
Start Trial
Evaxion AS --
Genmab A/S 27.00
Ascendis Pharma A/S 19.00
Zealand Pharma A/S 8.216
Agenus, Inc. 2.946

PE Ratio Related Metrics